Coverage
-
June 05, 2023
The U.S. Judicial Panel on Multidistrict Litigation has decided to consolidate 18 suits accusing Horizon Pharmaceuticals Inc. of not telling patients a drug it developed to treat thyroid eye disease can cause permanent hearing damage.
1 other articles on this case.
View all »